skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 132,026  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis
Material Type:
Article 		Add to My Research

Tezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic Fibrosis

The New England journal of medicine, 2017-11, Vol.377 (21), p.2024-2035 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709847 ;PMID: 29099333

Full text available

Citations Cited by
2
Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience
Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience
Material Type:
Article 		Add to My Research

Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience

PloS one, 2019-09, Vol.14 (9), p.e0223287-e0223287 [Peer Reviewed Journal]

COPYRIGHT 2019 Public Library of Science ;COPYRIGHT 2019 Public Library of Science ;2019 Mangia et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Mangia et al 2019 Mangia et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0223287 ;PMID: 31553772

Full text available

Citations Cited by
3
Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del
Material Type:
Article 		Add to My Research

Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del

The New England journal of medicine, 2017-11, Vol.377 (21), p.2013-2023 [Peer Reviewed Journal]

Copyright © 2017 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1709846 ;PMID: 29099344

Full text available

Citations Cited by
4
Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice
Material Type:
Article 		Add to My Research

Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice

BMC pulmonary medicine, 2022-03, Vol.22 (1), p.113-113, Article 113 [Peer Reviewed Journal]

COPYRIGHT 2022 BioMed Central Ltd. ;2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 1471-2466 ;EISSN: 1471-2466 ;DOI: 10.1186/s12890-022-01876-5 ;PMID: 35351085

Full text available

Citations Cited by
5
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Short telomeres are a risk factor for idiopathic pulmonary fibrosis
Material Type:
Article 		Add to My Research

Short telomeres are a risk factor for idiopathic pulmonary fibrosis

Proceedings of the National Academy of Sciences - PNAS, 2008-09, Vol.105 (35), p.13051-13056 [Peer Reviewed Journal]

Copyright 2008 The National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences Sep 2, 2008 ;2008 by The National Academy of Sciences of the USA ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.0804280105 ;PMID: 18753630

Full text available

Citations Cited by
6
Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis
Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis
Material Type:
Article 		Add to My Research

Blockade of IL-6 Trans signaling attenuates pulmonary fibrosis

The Journal of immunology (1950), 2014-10, Vol.193 (7), p.3755-3768 [Peer Reviewed Journal]

Copyright © 2014 by The American Association of Immunologists, Inc. ;Copyright © 2014 by The American Association of Immunologists, Inc. 2014 Copyright © 2014 by The American Association of Immunologists, Inc. ;ISSN: 0022-1767 ;EISSN: 1550-6606 ;DOI: 10.4049/jimmunol.1302470 ;PMID: 25172494

Full text available

Citations Cited by
7
Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorbeta;1-Driven Lung Fibrosis
Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorbeta;1-Driven Lung Fibrosis
Material Type:
Article 		Add to My Research

Low-Dose of Intrapulmonary Pirfenidone Improves Human Transforming Growth Factorbeta;1-Driven Lung Fibrosis

Frontiers in pharmacology, 2020-11 [Peer Reviewed Journal]

COPYRIGHT 2020 Frontiers Research Foundation ;ISSN: 1663-9812 ;EISSN: 1663-9812

Full text available

Citations Cited by
8
Emerging role of HMGB1 in fibrotic diseases
Emerging role of HMGB1 in fibrotic diseases
Material Type:
Article 		Add to My Research

Emerging role of HMGB1 in fibrotic diseases

Journal of cellular and molecular medicine, 2014-12, Vol.18 (12), p.2331-2339 [Peer Reviewed Journal]

2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. ;Copyright © 2014 John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine ;2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. 2014 ;ISSN: 1582-1838 ;EISSN: 1582-4934 ;DOI: 10.1111/jcmm.12419 ;PMID: 25284457

Full text available

Citations Cited by
9
Mechanotransduction in fibrosis
Mechanotransduction in fibrosis
Material Type:
Article 		Add to My Research

Mechanotransduction in fibrosis

Journal of Advanced Lung Health, 2023-05, Vol.3 (2), p.1

COPYRIGHT 2023 Medknow Publications and Media Pvt. Ltd. ;ISSN: 2772-7165

Full text available

Citations Cited by
10
Cystic fibrosis: a clinical view
Cystic fibrosis: a clinical view
Material Type:
Article 		Add to My Research

Cystic fibrosis: a clinical view

Cellular and molecular life sciences : CMLS, 2017, Vol.74 (1), p.129-140 [Peer Reviewed Journal]

Springer International Publishing 2016 ;Cellular and Molecular Life Sciences is a copyright of Springer, 2017. ;ISSN: 1420-682X ;EISSN: 1420-9071 ;DOI: 10.1007/s00018-016-2393-9 ;PMID: 27709245

Full text available

Citations Cited by
11
Fibrosis: from mechanisms to medicines
Fibrosis: from mechanisms to medicines
Material Type:
Article 		Add to My Research

Fibrosis: from mechanisms to medicines

Nature (London), 2020-11, Vol.587 (7835), p.555-566 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Nov 26, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2938-9 ;PMID: 33239795

Full text available

Citations Cited by
12
Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
Material Type:
Article 		Add to My Research

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation

American journal of respiratory and critical care medicine, 2013-06, Vol.187 (11), p.1219-1225 [Peer Reviewed Journal]

2014 INIST-CNRS ;Copyright American Thoracic Society Jun 1, 2013 ;Copyright © 2013 by the American Thoracic Society 2013 ;ISSN: 1073-449X ;EISSN: 1535-4970 ;DOI: 10.1164/rccm.201301-0153OC ;PMID: 23590265

Full text available

Citations Cited by
13
Spectrum of Fibrotic Lung Diseases
Spectrum of Fibrotic Lung Diseases
Material Type:
Article 		Add to My Research

Spectrum of Fibrotic Lung Diseases

The New England journal of medicine, 2020-09, Vol.383 (10), p.958-968 [Peer Reviewed Journal]

Copyright © 2020 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2005230 ;PMID: 32877584

Full text available

Citations Cited by
14
Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis
Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis
Material Type:
Article 		Add to My Research

Type V collagen induced tolerance suppresses collagen deposition, TGF-β and associated transcripts in pulmonary fibrosis

PloS one, 2013-10, Vol.8 (10), p.e76451 [Peer Reviewed Journal]

2013 Vittal et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2013 Vittal et al 2013 Vittal et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0076451 ;PMID: 24204629

Full text available

Citations Cited by
15
Pulmonary fibrosis: patterns and perpetrators
Pulmonary fibrosis: patterns and perpetrators
Material Type:
Article 		Add to My Research

Pulmonary fibrosis: patterns and perpetrators

The Journal of clinical investigation, 2012-08, Vol.122 (8), p.2756-2762 [Peer Reviewed Journal]

COPYRIGHT 2012 American Society for Clinical Investigation ;COPYRIGHT 2012 American Society for Clinical Investigation ;Copyright American Society for Clinical Investigation Aug 2012 ;Copyright © 2012, American Society for Clinical Investigation 2012 ;ISSN: 0021-9738 ;EISSN: 1558-8238 ;DOI: 10.1172/jci60323 ;PMID: 22850886

Full text available

Citations Cited by
16
Structure-guided combination therapy to potently improve the function of mutant CFTRs
Structure-guided combination therapy to potently improve the function of mutant CFTRs
Material Type:
Article 		Add to My Research

Structure-guided combination therapy to potently improve the function of mutant CFTRs

Nature medicine, 2018-11, Vol.24 (11), p.1732-1742 [Peer Reviewed Journal]

COPYRIGHT 2018 Nature Publishing Group ;COPYRIGHT 2018 Nature Publishing Group ;Copyright Nature Publishing Group Nov 2018 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-018-0200-x ;PMID: 30297908

Full text available

Citations Cited by
17
A functional CFTR assay using primary cystic fibrosis intestinal organoids
A functional CFTR assay using primary cystic fibrosis intestinal organoids
Material Type:
Article 		Add to My Research

A functional CFTR assay using primary cystic fibrosis intestinal organoids

Nature medicine, 2013-07, Vol.19 (7), p.939-945 [Peer Reviewed Journal]

COPYRIGHT 2013 Nature Publishing Group ;COPYRIGHT 2013 Nature Publishing Group ;Copyright Nature Publishing Group Jul 2013 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/nm.3201 ;PMID: 23727931

Full text available

Citations Cited by
18
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length
Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length
Material Type:
Article 		Add to My Research

Pulmonary fibrosis 4 months after COVID-19 is associated with severity of illness and blood leucocyte telomere length

Thorax, 2021-12, Vol.76 (12), p.1242-1245 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0040-6376 ;EISSN: 1468-3296 ;DOI: 10.1136/thoraxjnl-2021-217031 ;PMID: 33927016

Full text available

Citations Cited by
19
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
Material Type:
Article 		Add to My Research

SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis

Cell, 2021-12, Vol.184 (26), p.6243-6261.e27 [Peer Reviewed Journal]

2021 ;Copyright © 2021. Published by Elsevier Inc. ;2021 Published by Elsevier Inc. 2021 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.11.033 ;PMID: 34914922

Full text available

Citations Cited by
20
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis
Material Type:
Article 		Add to My Research

The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis

Respiratory research, 2018-07, Vol.19 (1), p.141-141, Article 141 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s). 2018 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-018-0845-5 ;PMID: 30055613

Full text available

Citations Cited by

Results 1 - 20 of 132,026  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (117,913)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1960  (619)
  2. 1960 To 1975  (2,150)
  3. 1976 To 1991  (7,396)
  4. 1992 To 2008  (28,286)
  5. After 2008  (93,337)
  6. More options open sub menu

Subject 

  1. Science & Technology  (98,104)
  2. Life Sciences & Biomedicine  (89,341)
  3. Humans  (65,545)
  4. Fibrosis  (56,059)
  5. Male  (36,884)
  6. Animals  (31,849)
  7. Female  (29,479)
  8. Cystic Fibrosis  (28,137)
  9. Adult  (17,610)
  10. Biological And Medical Sciences  (17,251)
  11. Medical Sciences  (15,665)
  12. Mice  (15,322)
  13. Middle Aged  (15,296)
  14. Inflammation  (14,598)
  15. Respiratory System  (12,226)
  16. Proteins  (11,247)
  17. Pulmonary Fibrosis  (11,013)
  18. Patients  (10,129)
  19. Cell Biology  (9,966)
  20. General & Internal Medicine  (9,769)
  21. More options open sub menu

Language 

  1. English  (127,969)
  2. Japanese  (17,230)
  3. French  (1,181)
  4. Portuguese  (1,168)
  5. Spanish  (902)
  6. German  (866)
  7. Korean  (600)
  8. Russian  (368)
  9. Chinese  (334)
  10. Turkish  (104)
  11. Polish  (93)
  12. Norwegian  (86)
  13. Italian  (72)
  14. Persian  (44)
  15. Ukrainian  (34)
  16. Catalan  (29)
  17. Swedish  (23)
  18. Czech  (19)
  19. Dutch  (16)
  20. Croatian  (11)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait